UTHR FY 2017 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.7B+7.9% YoY

Gross Profit

$1.6B93.9% margin

Operating Income

$815M47.2% margin

Net Income

$418M24.2% margin

EPS (Diluted)

$9.31

Cash Flow

Operating Cash Flow

$474M

Free Cash Flow

$388M

Stock-Based Comp.

$74M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$778M

Stockholders' Equity

$2.1B

Cash & Equivalents

$705M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+7.9%
Gross Profit	$1.6B	$1.5B	+6.1%
Operating Income	$815M	$1.1B	-23.2%
Net Income	$418M	$714M	-41.4%